T cell-directed therapies: lessons learned and future prospects.
about
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesDevelopment of a Fluorescent Quenching Based High Throughput Assay to Screen for Calcineurin InhibitorsTransition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model.HDAC inhibition and graft versus host diseaseT-cell activation and transplantation tolerance.1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept.Pathophysiology of acute graft-versus-host disease: recent advances.Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized studyT-cell-targeted signaling inhibitors.Examining the chirality, conformation and selective kinase inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550)Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.Current advances and travails in islet transplantation.Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.New perspectives on the biology of acute GVHD.GVHD prevention: an ounce is better than a pound.Current pharmacotherapeutical options for the prevention of kidney transplant rejection.Discovery of a latent calcineurin inhibitory peptide from its autoinhibitory domain by docking, dynamic simulation, and in vitro methods.New therapeutic targets in immune disorders: ItpkB, Orai1 and UNC93B
P2860
Q26751959-96144C08-EB04-43B9-A500-D23B7D3204C9Q28546525-3EE88CA7-CC7A-435A-B5E9-4962DB84A420Q33755928-B86C3320-7E06-4252-8F96-CD4BABE773B9Q35016985-B521E74C-CF6D-4555-B64B-BDBCDB054A13Q35803977-DD597A8B-CD43-4A41-BEEF-7DC2490FE390Q36029113-C313229E-3D16-40B9-AB9B-FD8BC29E0A9FQ36156559-75A5176A-FDA4-4E82-9EB8-B97E10BF8C97Q37022116-8B43953B-9BAC-4C5F-BDD2-118DF484EDD1Q37094686-736E46A4-D081-42E8-8CC6-47B92CF0DFCDQ37139740-56D7986B-CB76-4861-9ABB-FE20654533D4Q37215167-C8E53B6D-861F-491F-B492-06827E628848Q37270803-68203525-98D9-4117-85F1-E60343AC9F13Q37360411-F4F8B840-EA6F-4708-96FD-607ED890F0FFQ37372782-A1F0C774-42A6-4863-A4F6-E54D95F7040BQ37486715-FCB30094-E68B-49B6-A58F-88B1B0A95E39Q37641063-2A86C013-59D7-47B9-BAEC-67071E0DDBEAQ37973859-FAE83934-9C1B-407A-8312-B5B8F3EC4030Q38096463-880A34EA-C27B-4A11-BDF4-05C30A3A9F50Q50264758-EA12951B-F45A-4E75-945D-7B24602C2916Q57201013-4FE10EAC-D88A-4D74-B372-A065C2802E7B
P2860
T cell-directed therapies: lessons learned and future prospects.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
T cell-directed therapies: lessons learned and future prospects.
@ast
T cell-directed therapies: lessons learned and future prospects.
@en
type
label
T cell-directed therapies: lessons learned and future prospects.
@ast
T cell-directed therapies: lessons learned and future prospects.
@en
prefLabel
T cell-directed therapies: lessons learned and future prospects.
@ast
T cell-directed therapies: lessons learned and future prospects.
@en
P2093
P2860
P356
P1433
P1476
T cell-directed therapies: lessons learned and future prospects.
@en
P2093
David M Harlan
Eric H Liu
John J O'Shea
Richard M Siegel
P2860
P356
10.1038/NI1429
P407
P577
2007-01-01T00:00:00Z